Drug intelligence / Profile preview

Dingguiyou

Development stage
Unknown
Lead developer
Chengdu Shangke Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

Dingguiyou is a Chinese patent medicine (CPM) developed by Chengdu Shangke Pharmaceutical Co., Ltd., primarily indicated for the treatment of irritable bowel syndrome (IBS), particularly the diarrhea-predominant subtype (IBS-D). It is a fixed-dose combination of clove oil (extracted from *Syzygium aromaticum*) and cinnamon oil (extracted from *Cinnamomum cassia*). The therapeutic efficacy of Dingguiyou is attributed to its primary bioactive constituents, eugenol and cinnamaldehyde, which exert antispasmodic, anti-inflammatory, and analgesic effects. The drug works by regulating gastrointestinal motility and reducing visceral hypersensitivity, often through the modulation of transient receptor potential (TRP) channels. It is typically formulated as soft capsules for oral administration and has been approved for marketing in China.

Brand names
Dingguiyou
Other names
Clove and Cinnamon OilDingxiang Rougui OilDingguiyou Soft Capsules
02

Targets

TRPV1 (Transient receptor potential cation channel subfamily V member 1)TRPA1 (Transient receptor potential cation channel subfamily A member 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on Dingguiyou.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dingguiyou.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call